CS
TMDX icon

Credit Suisse’s Transmedics TMDX Stock Holding History

Credit Suisse’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$62.7M Sell
847,885
-11,593
-1% -$956K 0.06% 316
2023
Q4 		$67.8M Sell
859,478
-272,425
-24% -$16.4M 0.07% 297
2023
Q3 		$62M Buy
1,131,903
+344,635
+44% +$24.8M 0.06% 323
2023
Q2 		$66.1M Sell
787,268
-34,741
-4% -$2.66M 0.07% 313
2023
Q1 		$62.3M Sell
822,009
-215,288
-21% -$14.9M 0.06% 323
2022
Q4 		$64M Sell
1,037,297
-128,028
-11% -$6.81M 0.07% 311
2022
Q3 		$48.6M Sell
1,165,325
-325,325
-22% -$14.1M 0.05% 378
2022
Q2 		$46.9M Sell
1,490,650
-26,877
-2% -$717K 0.05% 407
2022
Q1 		$40.9M Buy
1,517,527
+1,159
+0.1% +$20.8K 0.04% 521
2021
Q4 		$29.1M Buy
1,516,368
+75
+0% +$1.88K 0.02% 894
2021
Q3 		$50.2M Buy
1,516,293
+2,332
+0.2% +$71.3K 0.03% 642
2021
Q2 		$50.2M Buy
1,513,961
+11,194
+0.7% +$310K 0.03% 687
2021
Q1 		$62.4M Sell
1,502,767
-4,126
-0.3% -$127K 0.03% 611
2020
Q4 		$30M Buy
1,506,893
+8,286
+0.6% +$123K 0.01% 956
2020
Q3 		$20.7M Buy
1,498,607
+195,849
+15% +$3.36M 0.01% 1012
2020
Q2 		$23.3M Buy
1,302,758
+102,537
+9% +$1.6M 0.02% 870
2020
Q1 		$14.5M Buy
1,200,221
+68,376
+6% +$1.15M 0.01% 994
2019
Q4 		$21.5M Buy
1,131,845
+365,271
+48% +$6.71M 0.02% 973
2019
Q3 		$18.2M Buy
766,574
+115,534
+18% +$2.77M 0.02% 975
2019
Q2 		$18.9M Buy
+651,040
New +$17.8M 0.02% 961

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Credit Suisse's TMDX Position: Q1 2024 in Review

Credit Suisse reduced its Transmedics (TMDX) stake by 1.3% in Q1 2024, selling an estimated $956K and leaving 847,885 shares worth $62.7M. The position accounts for 0.06% of the portfolio, ranked #316.

Credit Suisse first reported a position in TMDX in Q2 2019 and has held it in 20 quarters since. The position peaked at $67.8M in Q4 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Credit Suisse held 847,885 shares of Transmedics worth $62.7M as of Q1 2024.
  • Credit Suisse sold 11,593 Transmedics shares in Q1 2024, an estimated $956K.
  • Transmedics made up 0.06% of Credit Suisse's portfolio in Q1 2024, its #316 holding.
  • Credit Suisse first reported a position in Transmedics in Q2 2019 and has held it in 20 quarters since.
  • Credit Suisse's Transmedics position peaked at $67.8M in Q4 2023.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.